YIMXELFA

Class [005]
Pharmaceutical preparations for the treatment of: psychiatric diseases, degenerative nerve diseases and brain disorders, namely, mood, anxiety and cognitive disorders, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis; seizures; neuromuscular diseases and disorder, namely, brain, central nervous system, muscle, ocular motility and spinal cord infections, injuries and diseases; cranial and facial nerve disorders; tissue injuries, diseases and disorders; bone and cartilage injuries, diseases and disorders; genitourinary diseases, namely, pelvic, urological and reproductive system diseases and disorders, and infections, sexually transmitted diseases, erectile and sexual dysfunction, infertility and incontinence; auto-immune, cardiovascular, gastrointestinal, hematologic, oncological, ophthalmological and respiratory system diseases and disorders; pharmaceutical preparations for the relief of allergies, hypertension, menopause diabetic neuropathy, and pain; antibiotics and anti-infectives, anti-inflammatories, anti-fungals, anti-virals, oral and injectable contraceptives, human vaccines; smoking cessation medications; pharmaceutical preparations for the treatment of renal disease and disorders; diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; muscular atrophy; inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders; and metabolic diseases and disorders, namely diabetes, hypoglycemia, gout, muscular dystrophy, sickle cell disease, and anemia. Pharmaceutical preparations for the treatment of alopecia areata, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis.